10/15/2026
Can noninvasive brain stimulation help protect cognition in Parkinson’s disease?
Mild cognitive impairment in Parkinson’s (PD-MCI) is a critical window before dementia, yet non-drug options for supporting cognition at this stage remain poorly understood.
This scoping review, led by our Applied Health & Performance Division, maps the evidence on five noninvasive neuromodulation approaches, from transcranial stimulation to vagus nerve stimulation. We found the research promising but early: few studies enrolled patients with confirmed PD-MCI, results were mixed, and samples were small. The review outlines what future trials need to do to turn promise into proof.
At Sophic Synergistics, our work centers on understanding how people think, perform, and stay safe, and this review extends that human-centered focus into brain health. We’re proud of our team for contributing rigorous, independent research to this growing field.
Read the full article at: https://www.mdpi.com/2076-3425/16/10/1086
Background/Objectives: Parkinson’s disease with mild cognitive impairment (PD-MCI) represents a critical early-intervention window before progression to dementia. However, non-pharmacological cognitive treatment options are poorly characterized. This scoping review maps noninvasive neuromodulation...